1. Targeted therapy with polymeric nanoparticles in PBRM1-mutant biliary tract cancers: Harnessing DNA damage repair mechanisms
   Hrushikesh Wagh et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
2. Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report
   Xiaolong Yue et al, 2024, Frontiers in Pharmacology CrossRef
3. SIRT4 in ageing
   Ling He et al, 2023, Biogerontology CrossRef
4. The m6A demethylase FTO targets POLQ to promote ccRCC cell proliferation and genome stability maintenance
   Yichen He et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
5. Novel small molecule inhibitors targeting renal cell carcinoma: Status, challenges, future directions
   Lin Xiong et al, 2024, European Journal of Medicinal Chemistry CrossRef
6. Ferroptosis-associated genes and compounds in renal cell carcinoma
   Chengwu He et al, 2024, Frontiers in Immunology CrossRef
7. Targeted DNA damage repair: old mechanisms and new opportunities in clear cell renal cell carcinoma
   Jiahua Lv et al, 2024, Genome Instability & Disease CrossRef
8. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications
   Cigir Biray Avci et al, 2024, Frontiers in Pharmacology CrossRef